TT

Tal Teitz

Co-Founder

Ting Therapeutics

Therapeutic Areas

Ting Therapeutics Pipeline

DrugIndicationPhase
Otoprotectant for Aminoglycoside-Induced Hearing LossPrevention of chemotherapy-induced ototoxicityPre-clinical